As of 2025-12-18, the Relative Valuation of Theravance Biopharma Inc (TBPH) is 12.25 USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.53 USD, the upside of Theravance Biopharma Inc based on Relative Valuation is -30.1%.
The range of the Relative Valuation is 6.81 - 23.20 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.8x - 26.6x | 12.0x |
| Forward P/E multiples | 22.0x - 40.1x | 30.3x |
| Fair Price | 6.81 - 23.20 | 12.25 |
| Upside | -61.1% - 32.3% | -30.1% |
| Date | P/E |
| 2025-12-16 | 30.39 |
| 2025-12-15 | 30.68 |
| 2025-12-12 | 31.38 |
| 2025-12-11 | 30.53 |
| 2025-12-10 | 30.41 |
| 2025-12-09 | 30.75 |
| 2025-12-08 | 31.29 |
| 2025-12-05 | 32.03 |
| 2025-12-04 | 32.29 |
| 2025-12-03 | 32.62 |
| 2025-12-02 | 31.82 |
| 2025-12-01 | 33.86 |
| 2025-11-28 | 35.05 |
| 2025-11-26 | 34.47 |
| 2025-11-25 | 32.70 |
| 2025-11-24 | 31.95 |
| 2025-11-21 | 31.91 |
| 2025-11-20 | 30.91 |
| 2025-11-19 | 30.62 |
| 2025-11-18 | 31.93 |
| 2025-11-17 | 31.15 |
| 2025-11-14 | 30.03 |
| 2025-11-13 | 31.00 |
| 2025-11-12 | 30.70 |
| 2025-11-11 | 31.95 |
| 2025-11-10 | 26.04 |
| 2025-11-07 | 25.47 |
| 2025-11-06 | 25.68 |
| 2025-11-05 | 25.82 |
| 2025-11-04 | 25.47 |
| 2025-11-03 | 26.28 |
| 2025-10-31 | 25.31 |
| 2025-10-30 | 24.69 |
| 2025-10-29 | 24.47 |
| 2025-10-28 | 24.35 |
| 2025-10-27 | 24.69 |
| 2025-10-24 | 24.66 |
| 2025-10-23 | 24.42 |
| 2025-10-22 | 24.17 |
| 2025-10-21 | 24.19 |
| 2025-10-20 | 24.71 |
| 2025-10-17 | 24.62 |
| 2025-10-16 | 24.24 |
| 2025-10-15 | 24.00 |
| 2025-10-14 | 23.92 |
| 2025-10-13 | 24.04 |
| 2025-10-10 | 24.16 |
| 2025-10-09 | 25.06 |
| 2025-10-08 | 24.93 |
| 2025-10-07 | 24.78 |